First Time Loading...
X

Xenon Pharmaceuticals Inc
NASDAQ:XENE

Watchlist Manager
Xenon Pharmaceuticals Inc
NASDAQ:XENE
Watchlist
Price: 44 USD 0.57%
Updated: May 6, 2024

Xenon Pharmaceuticals Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Xenon Pharmaceuticals Inc
Cash from Investing Activities Peer Comparison

Comparables:
ZYME
RPTX
FUSN
AUPH
EDT

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
X
Xenon Pharmaceuticals Inc
NASDAQ:XENE
Cash from Investing Activities
-$117.2m
CAGR 3-Years
-91%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Zymeworks Inc
NYSE:ZYME
Cash from Investing Activities
-$207.3m
CAGR 3-Years
-68%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Cash from Investing Activities
$78m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Cash from Investing Activities
-$42.8m
CAGR 3-Years
41%
CAGR 5-Years
-107%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Cash from Investing Activities
-$6.7m
CAGR 3-Years
65%
CAGR 5-Years
-149%
CAGR 10-Years
-67%
Spectral Medical Inc
TSX:EDT
Cash from Investing Activities
-CA$185k
CAGR 3-Years
15%
CAGR 5-Years
-30%
CAGR 10-Years
N/A

See Also

What is Xenon Pharmaceuticals Inc's Cash from Investing Activities?
Cash from Investing Activities
-117.2m USD

Based on the financial report for Dec 31, 2023, Xenon Pharmaceuticals Inc's Cash from Investing Activities amounts to -117.2m USD.

What is Xenon Pharmaceuticals Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-32%

Over the last year, the Cash from Investing Activities growth was 60%. The average annual Cash from Investing Activities growth rates for Xenon Pharmaceuticals Inc have been -91% over the past three years , -32% over the past five years .